CUA Educational Content

Management of non-clear cell RCC - a review of the 2024 CUA-KCRNC Expert Report

Speakers: Jeffrey Graham, Susan Prendeville & Patrick Richard

Objectives

By participating in this learning program, healthcare providers can expect to gain an understanding of:

  • Briefly summarize and review the WHO 5th edition pathologic classification of RCC.
  • Review the management of localized non-clear cell RCC with a focus on papillary and chromophobe RCC.
  • Discuss the role of cytoreductive nephrectomy and metastasis directed therapy for metastatic papillary and chromophobe RCC.
  • Review the contemporary systemic therapy options for metastatic papillary and chromophobe RCC.
Start Quiz for Credits

ACCREDITATION

This activity is an Accredited Self-Assessment Program (Section 3) as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada, and approved by CUA. You may claim a maximum of 1 hour of credit.

This program has received financial support from BMS & Eisai in the form of an educational grant.

The Canadian Urological Association (CUA) does not provide professional medical advice, diagnosis or treatment and cannot respond to requests for direct feedback, specific patient information or physician referrals. You should first always seek the advice of your urologist, physician and other qualified health provider with any questions regarding your medical condition. The contents of the CUA Website such as text, graphics, images, and other content are for informational purposes only. The content/information is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Never disregard professional medical advice or delay in seeking it because of something you have read on the CUA website.

For comments or information, email Corporate.office@cua.org

Privacy Policy